Hercules Capital (HTGC) told investors its lending machine was disciplined. Strong underwriting. Careful valuations. A portfolio built to last. But that may not have been the full picture.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
A federal securities lawsuit filed against Hercules Capital, Inc. alleges the company misled investors about the rigor of its deal sourcing, portfolio valuation, and investment classification practices. The complaint alleges that these misrepresentations kept the stock artificially inflated before a media report triggered a sharp single-day decline.
The lawsuit covers investors who purchased Hercules Capital securities between May 1, 2025, and February 27, 2026. On February 27, 2026, following the publication of an investigative report, the company’s stock fell $1.22 per share, or approximately 7.9%, closing at $14.21 on unusually heavy trading volume.
Investors who purchased shares during this period and suffered losses may have legal options worth exploring.
Company Overview
Hercules Capital, Inc. is a Business Development Company incorporated in Maryland with its principal executive offices in San Mateo, California. The company describes itself as the largest non-bank source of venture financing in the market and a lender of choice for entrepreneurs and venture capital firms seeking growth capital. As of December 31, 2025, Hercules reported managing more than $5.7 billion in assets, with its common stock trading on the New York Stock Exchange under the ticker symbol “HTGC.” The company principally invests in debt securities, and its Net Asset Value is a key metric for investors and a statutory constraint on how much leverage the company can employ.
Alleged Misconduct and Omissions
The lawsuit alleges that throughout the class period, Hercules Capital publicly overstated the rigor of its deal sourcing process, its portfolio valuation procedures, and the accuracy of its investment classifications. According to the complaint, the company’s actual practices fell significantly short of what was represented to investors in SEC filings and earnings releases. The complaint further alleges that as a result of these alleged deficiencies, the company’s reported portfolio valuations were overstated or misrepresented, and that management’s positive statements about operations and prospects lacked a reasonable basis.
Investors tracking this case can follow developments for updates on court proceedings and class certification.
Management’s Public Statements
During the class period, Hercules Capital’s CEO Scott Bluestein described the company’s 2025 results as record-breaking, citing all-time highs in commitments, fundings, net portfolio growth, and investment income. In the company’s February 12, 2026, earnings release, Bluestein stated the results reflected the firm’s differentiated approach to investing and its unrivaled standing in the venture lending market. He described Hercules as maintaining disciplined underwriting as the hallmark of the company, and as committed to fundamental principles of disciplined credit and underwriting, and prudent leverage. The complaint identifies these statements as among the allegedly false or misleading representations made to investors during the class period.
How the Alleged Truth Emerged
On February 27, 2026, Hunterbrook Media published a report titled “The Myth of Hercules Capital,” which the complaint identifies as the corrective disclosure central to the case. The report cited a former Hercules analyst who described the company’s deal-sourcing process as going to the Google Ventures website, seeing what they invest in, and copying it. A second former employee from the finance team described the valuations group as a small, overstretched team of four people on a single reporting line, with few checks or cross-team reviews. The report also alleged that Hercules underrepresented its software debt exposure by classifying certain software companies into other categories, and that the company was marking its software loan portfolio at or above par despite widespread distress in that segment of the market. Following publication of the report, Hercules Capital’s stock fell 7.9% on February 27, 2026, closing at $14.21 per share on unusually heavy volume.
Why This Case May Matter to Shareholders
The lawsuit alleges that investors purchased Hercules Capital securities at prices artificially inflated by misleading statements about the company’s due diligence, valuation processes, and portfolio classifications. The complaint contends that the alleged corrective disclosures revealed that the company’s internal practices did not match its public representations, causing the stock to decline sharply. Investors who purchased shares during the class period from May 1, 2025, through February 27, 2026, may have suffered losses tied to this alleged inflation and subsequent correction. The case centers on whether Hercules’s public statements about due diligence, valuation practices, and portfolio classifications accurately reflected its internal practices.
Legal Framework
The lawsuit was filed in the United States District Court for the Northern District of California and asserts claims under Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5, which prohibit materially false or misleading statements in connection with the purchase or sale of securities. A second claim under Section 20(a) is brought against CEO Scott Bluestein and CFO Seth H. Meyer, alleged controlling persons with the authority to prevent or correct the statements at issue. The plaintiff alleges that Defendants either knew or recklessly disregarded that the representations about deal sourcing, valuation rigor, and portfolio classifications were materially false.
Investors who purchased Hercules Capital securities during the class period and wish to understand their legal rights can seek more information from qualified securities counsel.
About Levi & Korsinsky, LLP
Levi & Korsinsky, LLP is a nationally recognized securities litigation firm representing investors in complex shareholder actions. The firm has extensive expertise and a team of over 70 employees to serve our clients. Attorney advertising. Prior results do not guarantee similar outcomes.
Disclaimer: This article is provided for informational purposes only and does not constitute legal advice. No attorney-client relationship is created by reading this article. Past results do not guarantee similar outcomes.